alexa Interferon-based Antiviral Treatment Of Chronic Hepatitis C In Combination With Metformin In Patients With HCV-1 Genotype And Insulin Resistance
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

International Conference on Diabetes and Diabetic Nursing Care
September 20-21, 2017 Charlotte, USA

Olga Tarasova, O O Khafisova, N V Mazurchik and P P Ogurtsov
People’s Friendship University of Russia, Russia
Posters & Accepted Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156-C1-070
Abstract
Aim: To decide whether adding metformin an agent reducing insulin resistance (IR), improves treatment efficacy of chronic hepatitis C (genotype 1) in naïve patients. Methods: 133 treatment-naïve patients were tested: 70 patients with IR and 63 patients without it. 28 of 70 patients with IR received metformin. Metformin was added to a standard Peg-IFNα-2b/ribavirin therapy at the very start of treatment or 3-6 months before the start and continued throughout the whole course of treatment. Patients in the second control group with IR did not receive metformin (n=42). Patients in both groups receiving and not receiving metformin did not differ significantly in viral load, the degree of liver fibrosis (measured with FibroScan®502) and gender. Results: Among the patients with HCV-1 without IR, SVR rate was 46% (n=29/63) and in those who had IR (not receiving metformin) the rate of SVR was 42% (n=18/42), p=0.33. Among patients with HCV-1 and with IR, receiving metformin, the SVR rate was 64% (n=18/28), p=0.001. Significant reduction of glucose levels among patients with IR receiving metformin was not revealed. Conclusion: Adding metformin to a standard Peg-IFNα-2b/ribavirin therapy for treatment-naïve HCV-1 patients with IR leads to an increase of SVR by 1.5 times. Metformin is safe and efficient for patients with chronic hepatitis C and IR as a drug reducing IR.
Biography

Olga Tarasova is an Associate Professor of Hospital, Therapy department of RUDN University, Doctor-hepatologist of the Liver Research Center of the Medical Institute of RUDN University. She repeatedly spoke at international conferences of the American and European, Pacific associations for the study of liver diseases (DDW, AASLD, EASL, APASL) including Singapore, New York and Chicago. She has 15 years of experience in the treatment of patients with chronic and severe liver damage, hepatitis and cirrhosis based on the university's clinic. She has published more than 25 scientific and educational-methodical works.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version